Emergent BioSolutions Inc. - Laporan Laba Rugi (TTM)

Emergent BioSolutions Inc.
US ˙ NYSE ˙ US29089Q1058

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Emergent BioSolutions Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,333 1,577 1,706 1,709 1,652 1,774 1,757 1,580 1,491 1,118 974 1,072 1,103 1,049 1,185 1,102 1,126 1,044 965 852
Change (%) 18.35 8.15 0.16 -3.29 7.33 -0.92 -10.06 -5.64 -25.07 -12.81 10.06 2.85 -4.86 12.97 -7.02 2.11 -7.28 -7.49 -11.79
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 642 714 730 830 920 980 1,040 975 899 644 776 808 798 689 660 766 835 668 611 371
Change (%) 11.32 2.14 13.79 10.88 6.52 6.05 -6.26 -7.77 -28.30 20.43 4.07 -1.24 -13.60 -4.21 16.01 9.03 -20.00 -8.50 -39.25
% of Revenue 48.14 45.28 42.76 48.58 55.70 55.28 59.17 61.66 60.27 57.67 79.67 75.33 72.34 65.69 55.70 69.50 74.21 64.03 63.33 43.61
Gross Operating Profit 691 863 976 879 732 793 718 606 592 473 198 264 305 360 525 336 290 375 354 480
Change (%) 24.89 13.13 -10.02 -16.67 8.35 -9.54 -15.55 -2.21 -20.17 -58.12 33.52 15.35 17.99 45.86 -35.97 -13.65 29.31 -5.70 35.65
% of Revenue 51.86 54.72 57.24 51.42 44.30 44.72 40.83 38.34 39.73 42.33 20.33 24.67 27.66 34.31 44.30 30.50 25.79 35.97 36.67 56.39
SG&A 289 304 314 330 336 349 352 341 341 340 351 363 361 357 345 331 339 299 267 233
Change (%) 5.26 3.42 4.83 2.00 3.69 1.03 -3.24 -0.09 -0.32 3.39 3.36 -0.58 -1.11 -3.22 -4.06 2.39 -11.91 -10.75 -12.49
% of Revenue 21.68 19.28 18.44 19.30 20.35 19.66 20.05 21.57 22.84 30.38 36.03 33.83 32.70 33.99 29.12 30.05 30.13 28.62 27.62 27.40
R&D 183 38 106 106 106 64 64 64
Change (%) -79.22 0.00 0.00 0.00 0.00
% of Revenue 16.37 3.90 10.08 8.93 9.60 6.11 6.61 7.49
OpEx 990 1,078 1,104 1,220 1,316 1,388 1,450 1,372 1,296 1,227 1,228 1,236 1,226 1,217 1,176 1,268 1,239 1,096 1,007 734
Change (%) 8.89 2.39 10.50 7.90 5.42 4.47 -5.35 -5.58 -5.30 0.11 0.61 -0.79 -0.69 -3.39 7.81 -2.26 -11.58 -8.10 -27.15
% of Revenue 74.29 68.35 64.71 71.39 79.65 78.24 82.49 86.81 86.86 109.78 126.05 115.23 111.14 116.02 99.22 115.04 110.11 105.00 104.31 86.14
Operating Income 343 499 602 489 336 386 308 208 196 -109 -254 -163 -123 -168 9 -166 -114 -52 -42 118
Change (%) 45.71 20.59 -18.79 -31.21 14.78 -20.31 -32.22 -6.04 -155.79 132.20 -35.66 -24.74 36.78 -105.53 -1,882.80 -31.36 -54.13 -20.31 -383.65
% of Revenue 25.71 31.65 35.29 28.61 20.35 21.76 17.51 13.19 13.14 -9.78 -26.05 -15.23 -11.14 -16.02 0.78 -15.04 -10.11 -5.00 -4.31 13.86
Interest Expense -32 -31 -31 -33 -34 -34 -34 -33 -34 -37 -47 -68 -79 -88 -94 -89 -78 -71 -61 -52
Change (%) -1.26 -0.32 7.05 2.40 0.88 -0.87 -2.34 0.30 11.34 26.01 44.26 16.52 11.27 7.28 -5.30 -12.77 -8.86 -13.52 -14.50
% of Revenue -2.38 -1.98 -1.83 -1.95 -2.07 -1.95 -1.95 -2.11 -2.25 -3.34 -4.82 -6.32 -7.16 -8.38 -7.96 -8.10 -6.92 -6.80 -6.36 -6.16
Net Income 167 306 387 299 227 220 158 88 33 -212 -394 -602 -778 -760 -565 -587 -209 -191 -132 140
Change (%) 83.55 26.65 -22.75 -24.13 -3.30 -28.25 -44.32 -62.03 -735.44 86.25 52.68 29.30 -2.25 -25.67 3.84 -64.43 -8.72 -30.95 -206.00
% of Revenue 12.50 19.39 22.70 17.51 13.74 12.38 8.96 5.55 2.23 -18.94 -40.45 -56.11 -70.54 -72.48 -47.69 -53.26 -18.55 -18.26 -13.63 16.38

Source: Capital IQ

Other Listings
GB:0IGA US$ 7.80
DE:ER4 € 6.66
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista